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Abstract:	
Cell-free	transcription-translation	platforms	have	been	widely	utilized	to	express	soluble	proteins	
in	basic	synthetic	biological	circuit	prototyping.	From	a	synthetic	biology	point	of	view,	it	is	critical	
to	 express	 membrane	 proteins	 in	 cell-free	 transcription-translation	 systems,	 and	 use	 them	
directly	 in	biocircuits,	 considering	 the	 fact	 that	histidine	kinases,	G-protein	coupled	 receptors	
(GPCRs)	 and	 other	 important	 biosensors	 are	 all	 membrane	 proteins.	 Previous	 studies	 have	
expressed	membrane	proteins	 in	 cell-free	 systems	with	 the	help	of	 detergents,	 liposomes	or	
nanodiscs,	but	have	not	demonstrated	the	ability	to	prototype	circuit	behavior	for	the	purpose	
of	testing	more	complex	circuit	functions	involving	membrane-bound	proteins.	Built	on	previous	
efforts,	 in	this	work	we	demonstrated	that	we	could	co-translationally	express	solubilized	and	
active	membrane	proteins	in	our	cell-free	TX-TL	platform	with	membrane-like	materials.	We	first	
tested	the	expression	of	several	constructs	with	β1	and	β2	adrenergic	 receptors	 in	TX-TL	and	
observed	significant	insoluble	membrane	protein	production.	The	addition	of	nanodiscs	to	the	
cell	free	expression	system	enabled	solubilization	of	membrane	proteins.	Nanodisc	is	lipoprotein-
based	membrane-like	material.	 The	 activity	 of	 β2	 adrenergic	 receptor	 was	 tested	 with	 both	
fluorescence	and	Surface	Plasmon	Resonance	 (SPR)	binding	assays	by	monitoring	 the	 specific	
binding	response	of	small-molecule	binders,	carazolol	and	norepinephrine.		Our	results	suggest	
that	it	is	promising	to	use	cell-free	expression	systems	to	prototype	synthetic	biocircuits	involving	
single	chain	membrane	proteins	without	extra	procedures.	This	data	made	us	one	step	closer	to	
testing	complex	membrane	protein	circuits	in	cell-free	environment.	
	
Introduction:	
Cell-free	 transcription-translation	 systems	 have	 shown	 to	 be	 extremely	 useful	 in	 synthetic	
biological	circuit	prototyping	[1,	2].	Typical	cell-free	transcription-translation	systems	are	based	
on	S30	E.	coli	extract	[3]	and	there	have	been	many	different	versions.	The	specific	version	used	
in	this	paper	referred	to	as	“TX-TL”,	has	been	optimized	for	prototyping	synthetic	biocircuits	[4,	
5].	Unlike	other	cell-free	protein	expression	systems,	including	the	PURE	system,	which	are	based	
on	bacteriophage	transcription	by	supplementing	bacteriophage	RNA	polymerases	to	the	crude	
cytoplasmic	extracts	[6],	TX-TL	has	been	shown	to	be	suitable	for	complex	biochemical	systems	
[1,	2,	4,	7].		
	
Membrane	proteins	play	important	roles	in	the	proper	functioning	of	cells	and	organisms.	They	
lay	the	foundation	for	many	biosensors	and	signal	pathways	in	cells	[8].	Some	membrane	proteins	
act	as	ion	channels	to	transport	ions	across	membranes	[9];	others	make	up	the	essential	parts	
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of	sensory	system	which	are	responsible	for	cell	communication	[10],	while	membrane	enzymes	
catalyze	important	chemical	reactions	near	membranes	[11].	In	addition,	membrane	proteins	are	
the	most	important	drug	targets,	for	example	more	than	half	of	therapeutics	for	treatment	of	
various	modalities	 ranging	 from	cancer	 to	cardiovascular	diseases	 	 target	membrane	proteins	
[12].	
	
Membrane	 proteins	 are	 difficult	 targets	 as	 compared	 to	 soluble	 proteins	 because	 of	 the	
challenges	associated	with	their	expression,	solubilization,	and	stabilization.		Typical	studies	of	
membrane	proteins	rely	on	proteins	produced	from	cells	and	solubilized	cell	membrane	using	
detergents,	 liposomes	 or	 other	 membrane-like	 materials.	 These	 approaches	 may	 have	
advantages	in	terms	of	protein	yield,	they	are	not	well-suited	for	high-throughput	selection	of	
protein	 constructs,	 	 since	 transformation,	 cell	 growth,	 lysis,	 membrane	 solubilization	 and	
purification	are	involved	for	each	construct	[13].	 It	 is	also	difficult	to	use	these	techniques	for	
biocircuits	prototyping,	which	require	prompt	function	of	the	newly	expressed	proteins.	
	
Recently	 cell	 free	 expression	 of	 membrane	 protein	 have	 been	 reported	 using	 detergents,	
liposomes	or	nanodiscs	to	solubilize	and	stabilize	the	proteins	[13-19].	Our	data	 indicated	the	
possibility	to	integrate	membrane	proteins	directly	into	future	synthetic	biocircuits	with	complex	
functions.		Among	all	the	important	membrane	proteins,	we	picked	G	protein	coupled	receptors	
(GPCRs),	beta-2(and	1)	adrenergic	 receptors	 (β2AR/β1AR)	as	model	proteins.	With	more	than	
900	members,	GPCRs	are	one	of	the	most	important	and	the	largest	integral	membrane	proteins	
family	in	human	cells	and	the	most	important	clinical	drug	targets	as	they	play	important	roles	in	
many	physiological	functions	and	implicated	in	many	diseases	[12,	20,	21].	GPCRs	all	share	the	
same	topology	–	seven	transmembrane	a-helices,	and	they	are	thought	to	function	in	monomeric	
form	[22],	although	there	have	been	studies	indicating	their	dimerization	[23,	24].	We	used	TX-
TL	 platform	 in	 combination	with	 nanodisc	 for	 expressing	 β2AR/β1AR	 and	 subsequent	 in	 situ	
stabilization.	Furthermore,	biological	activity	of	these	proteins	was	confirmed	by	binding	to	its	
ligands.						
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Results	and	Discussion:	
	
We	ordered	gene	 synthesis	 services	and	 then	used	golden	gate	assembly	 [27]	 to	make	 three	
different	GPCR	constructs	with	three	different	variants,	which	share		similar	backbone,	promoter,	
ribosome	binding	sites	and	terminator	(Figure	1);	Figure	2	lists		the	difference	in	coding	sequences	
corresponding	to	various	adrenergic	receptor	constructs.	All	three	constructs	shared	the	same	
superfolder	 GFP	 (sfGFP)	 fusion	 protein	 topology,	 which	was	 tagged	with	 6xHis	 tag	 at	 the	 C-
terminal	of	the	protein.	sfGFP	is	used	for	monitoring	and	estimation	of	target	protein	expression	
level	during	and	at	the	end	of	TX-TL.	Whereas,	6xHis	tag	was	used	to	detect	proteins	in	Western,	
to	capture	the	protein	for	binding	assays,	and	for	affinity	purification,	if	necessary.			
	
One	of	the	advantages	of	TX-TL	expression	platform	is	that	we	could	use	either	linear	DNA	or	
plasmid	DNA	 for	expression	 in	TX-TL	 [7].	Because	of	 that,	we	could	 implement	 fast	 construct	
prototyping	in	TX-TL	by	ligating	parts	together	and	amplifying	the	linear	DNAs	with	PCR,	avoiding			
cloning	the	linear	fragments	into	plasmid.	To	express	these	constructs	in	TX-TL,	we	only	added	
A B
Figure	1.	 Illustration	of	the	plasmid	map	and	 linear	DNA	of	 the	constructs.	pSG73	 is	used	as	an	example.	pSG74	and	
pSG75	share	the	same	features	as	pSG73.	A:	Circular	plasmid	map	of	pSG73.	B:	Linear	DNA	version	of	pSG73.	
GPCR%Protein Construct Protein%Size
β1#AR#ts:)3ZPR)Thermostabilized)turkey)β1)adrenergic)receptor pSG73:)protein#sfGFP#His6 65kD)(35kD)minus)sfGFP)
β2#AR)wild)type:)ADRB2_HUMAN)β2)adrenergic)receptor pSG74:)protein#sfGFP#His6 75kD)(45kD)minus)sfGFP)
β2#AR#T4L:)2RH1)β2#adrenergic)receptor/T4#lysozyme)chimera pSG75:)protein#sfGFP#His6 85kD)(55kD)minus)sfGFP)
Figure	2.	 Information	of	GPCR	 constructs	used	 in	experiments.	pSG73	and	pSG75	have	the	corresponding	PDB	number	
noted.	Protein	size	of	each	fusion	protein	is	also	listed.	
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DNA	of	these	constructs	to	TX-TL	reaction	mix.		The	iteration	of	each	prototyping	test		significantly	
faster	(overnight)	compared	to	weeks		using		cloning	for	cell	(E.coli)	expression.		
	
	
We	first	estimated	the	expression	level	of	pSG73-75	in	TX-TL	by	measuring	the	fluorescence	of	
sfGFP	 which	 was	 fused	 at	 the	 C-terminal	 of	 β2AR	 or	 1AR,	 using	 a	 plate	 reader	 at	 485	 nm	
(absorbance)/525	nm	(emission).	All	the	linear	DNA	constructs	showed	a	GFP	fluorescence	signal,	
indicating	successful	expression	of	the	fusion	proteins	in	TX-TL	(Figure	3A).	Different	constructs,	
despite	having	exactly	the	same	promoter,	ribosome	binding	site,	fusion	protein	framework	and	
DNA	 concentration,	 showed	 different	 expression	 levels	 of	 sfGFP,	 especially	 pSG74.	 This	
suggested	that	the	difference	in	coding	sequences	could	affect	transcription	and	translation	level.	
Another	observation	was	that	increasing	linear	DNA	concentration	could	help	increase	the	fusion	
protein	expression,	but	this	increase	was	limited	by	TX-TL	resources	and/or	toxics	accumulated	
in	batch	mode,	as	shown	elsewhere	[28].	Setting	up	TX-TL	reactions	in	dialysis	systems	is	likely	to	
improve	the	protein	expression	level.	
	
After	 testing	 the	 fusion	 protein	 expression	 level,	 we	 explored	 the	 possibility	 of	 stabilizing	
hydrophobic	membrane	protein	by	providing	a	membrane	mimic	 into	the	reaction.	Detergent	
micelle,	liposome	and	nanodisc	are	commonly	used	to	provide	artificial	bilayer	environment	to	
membrane	protein	 (Ref).	We	observed	that	majority	of	detergents	were	detrimental	 to	TX-TL	
reaction	comprising	membrane	protein	(data	not	shown).	Conversely,	reconstituting	protein	into	
liposome	 resulted	 into	 a	 poor	 yield	 of	 the	 folded	 protein,	 which	 could	 be	 attributed	 to	 the	
liposome’s	 closed	 topography.	 Therefore,	 we	 employed	 nanodisc	 −	 a	 lipid-protein	 complex,	
composed	 of	 lipids	 constrained	 by	 a	membrane	 scaffold	 protein	 (MSP).	 Nanodisc	 provides	 a	
robust	platform	with	two-dimensional	topography	for	reconstituting	TX-TL	expressed	membrane	
protein.	We	chose	two	of	 the	most	commonly	used	nanodiscs:	MSP1D1-DMPC	(ND1)	~10	nm	
diameter	and	a	longer	version,	MSP1E3D1-DMPG	(ND3)	~13	nm	in	diameter	[13].		
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Figure	3.	Expression	level	of	pSG73-75	constructs	in	TXTL	measured	by	sfGFP		A:	End	point	measurement	of	GFP	expression	
from	10nM,	20nM	and	40nM	linear	DNA	of	pSG73,	pSG74	and	pSG75	 in	10µL	TX-TL.	B:	 End	point	measurement	of	GFP	
expression	from	20nM	linear	DNA	of	pSG73-75	with	or	without	24µM	nanodiscs	in	TX-TL.	ND1	is	MSP1D1-DMPC	and	ND3	is	
MSP1E3D1-DMPG.	Measurements	were	done	at	29°C	 in	BIOTEK	Synergy	H1	Hybrid	Multi-Mode	Microplate	Reader	using	
ex485nm/em525nm.	
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We	repeated	the	TX-TL	expression	experiment	in	the	presence/absence	of	ND1	or	ND3.	As	shown	
in	Figure	3B,	the	presence	of	nanodisc	improves	the	TX-TL	efficiency,	as	indicated	by	enhanced	
GFP	 fluorescence.	 Nanodisc	 doesn’t	 have	 any	 intrinsic	 fluorescence,	 therefore	 the	 increased	
fluorescence	should	be	arising	from	the	fusion	protein.	GPCR-sfGFP	fusion	protein	precipitated	
in	 the	 TXTL	 reaction	 mix	 without	 nanodisc.	 However,	 in	 the	 presence	 of	 nanodisc,	 the	
supernatant	of	the	reaction	mixture	exhibited	increased	GFP	fluorescence	signal,	indicating	that	
nanodiscs	likely	to	help	stabilizing	fusion	membrane	proteins	in	TX-TL,	and	keep	the	folded	fusion	
protein	in	supernatant.	
	
To	further	confirm	that	the	target	fusion	proteins	were	expressed	in	TX-TL	and	nanodiscs	could	
help	solubilize	GPCR-sfGFP	fusion	proteins,	we	ran	SDS-PAGE	of	TX-TL	samples	and	western	blots	
with	an	anti-His6	antibody.	First,	we	ran	the	whole	reaction	samples	of	three	different	constructs	
at	three	different	concentrations	(Figure	4A).		
	
As	 illustrated	 on	 the	 blot,	 samples	 that	 had	 one	 of	 the	 three	 constructs	 showed	 significant	
detection	 of	 His-tagged	 proteins,	 protein	 size	 was	 confirmed	 on	 the	 blot	 using	 a	 ladder.	 In	
contrast,	control	sample	with	without	DNA	had	no	His-tagged	signal.	Additionally,	there	were	not	
significant	differences	between	different	concentrations	in	pSG73	and	pSG75,	suggesting	mass-
transfer	nutrients	 limitation	and	toxic	accumulation	 in	the	TX-TL	reaction	as	discussed	earlier.	
Another	interesting	observation	was	that	pSG73-β1-AR-ts	did	not	show	dimerization	but	pSG74	
Monomer
Dimer
No*DNA pSG73:*β14AR4ts
10nM 20nM 40nM 10nM 20nM 40nM 10nM 20nM 40nM
pSG74:*β24AR pSG75:*β24AR4T4L
Monomer
Dimer
pSG73:*β14AR4ts pSG74:*β24AR pSG75:*β24AR4T4L
Nanodisc ! ND1%%%%%ND3 ! ND1%%%%%ND3 ! ND1%%%%%ND3
A
B
Figure	4.	Western	blots	of	TX-TL	reactions.	A:	Results	of	whole	reaction	TX-TL	samples.	After	measuring	the	fluorescence	
of	the	TX-TL	reaction,	they	were	used	for	western	blot	using	the	method	in	Materials	and	Methods.	TX-TL	reaction	with	
no	DNA	was	used	as	negative	control	and	three	different	concentrations	of	three	different	constructs	were	run	under	the	
same	 condition.	 B:	 Results	 of	 only	 supernatant	 from	 TX-TL	 samples.	 Only	 soluble	 samples	 were	 run	 on	 this	 blot.	
Supernatants	without	any	nanodiscs	were	run	at	the	same	condition	as	ones	with	either	ND1	or	ND3.	
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and	pSG75,	which	were	both	β2-AR	based	fusion	proteins,	showed	strong	dimer	bands	on	the	
blot.	The	presence	of	GPCR	dimerization	is	consistent	with	previous	reports	[24].		
	
We	 further	 tested	 the	 presence	 of	 ND	 by	 spinning	 down	 the	 TX-TL	 reaction	 mix	 and	 took	
supernatant	only	to	run	the	western	blot.	All	the	insoluble	proteins	would	precipitate	out	and	
ended	up	in	the	pellet	after	centrifugation.	Only	soluble	proteins	would	be	in	the	supernatant	
and	can	be	detected	in	the	western	blot.	In	Figure	4B,	we	had	three	different	constructs	and	each	
of	them	had	three	different	experimental	conditions:	no	nanodisc;	with	ND1:	MSP1D1-DMPC;	
and	with	ND3:	MSP1E3D1-DMPG.	All	 target	proteins	 generated	 in	 TX-TL	precipitated	without	
nanodiscs	and	left	in	the	pellet	(confirmed	by	running	pellet	on	western	blot,	data	not	shown).	
On	the	contrary,	when	either	ND1	or	ND3	was	added	into	the	reaction,	we	saw	significant	bands	
of	 target	membrane	proteins	 by	 the	Western,	 suggesting	 that	 these	 hydrophobic	membrane	
proteins	became	soluble	with	help	from	nanodiscs.		
	
So	far	we	have	demonstrated	that	target	membrane	proteins	produced	in	TXTL	reactions	can	be	
solubilized	and	stabilized	with	in-situ	presence	of	nanodiscs.		However,	protein	association	with	
nanodisc	doesn’t	insure	that	these	proteins	are	biologically	active.	To	further	test	whether	these	
soluble	 proteins	 were	 active,	 we	 designed	 two	 binding	 assays:	 fluorescence-based	 carazolol	
binding	assay	and	SPR	based	norepinephrine	binding	assay.	
	
Although	there	is	no	need	to	purify	the	protein	for	circuit	prototyping,	purification	is	required	to	
confirm	the	binding	activity	of	TX-TL	expressed	protein	to	avoid	interference	caused	by	E.	coli	
endogenous	proteins	in	the	TX-TL	reaction	mix.			
	
We	used	Ni-NTA	 affinity	 chromatography	 to	 purify	His-tagged	 target	 protein.	 The	 protocol	 is	
described	in	Materials	and	Methods.		
	
Fluorescence-based	 carazolol	 binding	 assay	 uses	 (S)-carazolol,	 a	 derivative	 of	 the	 potent	 β	
blocker	carazolol	with	fluorescence	properties	(ex633nm/em650nm).	This	ligand	can	be	used	as	
a	fluorescence	tracker	for	β2AR	binding	activity.	The	detailed	experimental	setup	is	described	in	
Materials	 and	Methods.	Briefly,	 purified	membrane	proteins	were	 incubated	with	or	without	
carazolol	 for	 one	 hour.	 These	 samples	 were	 further	 dialyzed	 against	 100X	 volume	 buffer	
overnight.	Subsequently,	all	the	samples	were	concentrated	down	to	their	starting	volume	and	
fluorescence	 signal	 was	 measured	 in	 plate	 reader.	 Green	 fluorescence	 (GFP)	 indicates	 the	
amount	of	fusion	proteins	in	the	samples	and	red	fluorescence	would	represent	the	amount	of	
carazolol	bound	to	target	membrane	proteins	as	an	indication	of	protein	activity.	
	
We	used	two	different	ND1	(MSP1D1-DMPC)	in	this	assay:	1)	HisND	uses	6xHis	tagged	MSP1D1	
and	was	purchased	from	Cube	Biotech;	2)	BiotinND	uses	biotinylated	MSP1D1	and	was	made	in	
house.	As	seen	in	Figure	5B,	there	was	not	much	difference	in	green	fluorescence	signal	between	
the	samples.	However,	 there	 is	a	 significant	difference	between	ND1	samples	 incubated	with	
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carazolol.	We	attribute	high	carazolol	 signal	on	HisND	 reconstituted	β2AR	 to	 the	presence	of	
empty	ND	after	Ni-NTA	affinity	chromatography	purification.	
	
One	 limitation	 of	 fluorescence-based	 assay	 is	 that	 non-specific	 binding	 of	 carazolol	 to	 lipids	
surrounding	membrane	protein	could	cause	higher	signal-to-noise	ratio.	To	overcome	this,	we	
developed	a	SPR-based	binding	assay	using	norepinephrine,	which	is	a	partial	agonist	for	β2AR.	
Since	 norepinephrine	 shares	 the	 same	 binding	 pocket	 with	 carazolol	 [31],	 we	 tethered	
norepinephrine	to	the	surface	via	amide	bond	between	its	primary	amine	and	the	carboxyl	group	
on	 the	 surface.	We	 hypothesized	 that	 carazolol	 could	 be	 used	 as	 a	 competitor	 for	 β2AR	 to	
norepinephrine	binding	on	SPR.	As	shown	in	Figure	5C.,	SPR	binding	response	of	β2AR	decreased	
~60%	when	it	was	incubated	with	1µM	carazolol,	indicating	specific	interaction	between	β2AR	
and	its	binding	partners.	
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Figure	5.	Binding	assays	of	TX-TL	made	β1	and	β2	adrenergic	receptor.	A:	Bar	chart	of	carazolol	fluorescence	fold	change.	
The	number	was	the	ratio	of	red	fluorescence	signal	from	samples	incubated	with	carazolol	to	the	ones	without	carazolol.	
Detailed	experimental	method	is	in	Materials	and	Methods.	All	samples	were	dialyzed	against	buffer	without	carazolol	to	
remove	non-binding	carazolol.	B:	Bar	chart	of	GFP	fluorescence	fold	change	with	the	same	samples	from	A.	The	number	was	
the	ratio	of	 green	fluorescence	 signal	 from	 samples	 incubated	with	 carazolol	 to	 the	ones	without	carazolol.	C:	 Response	
curves	of	β2	adrenergic	receptor	proteins	binding	to	SPR	surface	coated	with	norepinephrine.	Red	curve	was	response	signal	
from	β2-AR	 sample	without	carazolol.	Green	 curve	was	response	 signal	 from	sample	 incubated	with	1µM	carazolol	 as	a	
control.	D:	Bar	chart	of	the	end	point	of	the	response	curves	in	C.	
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To	summarize,	we	have	demonstrated	that	1)	membrane	protein	can	be	expressed	in	TX-TL	at	
analytical	 scale;	 2)	 presence	 of	 nanodisc	 during	 TX-TL	 reaction	 facilitates	 folding	 and	
solubilization	of	single	chain	membrane	protein;	3)	 fluorescence	and	SPR	binding	assays	were	
developed	to	demonstrate	specific	interaction	between	small-molecule	and	nanodisc-stabilized	
membrane	protein.		
	
Conclusions:	
	
In	this	work,	we	tested	proteins	from	the	GPCR	family	in	our	cell-free	transcription-translation	
(TX-TL)	 system,	 which	 would	 be	 ideal	 for	 synthetic	 biocircuit	 prototyping.	 We	 expressed	
β1AR/β2AR	 in	 TX-TL	 with	 nanodiscs	 and	 were	 able	 to	 show	 that	 not	 only	 these	 membrane	
proteins	 are	 soluble	 in	 TX-TL	 with	 nanodiscs,	 but	 they	 were	 also	 active.	 Nanodiscs	 are	 co-
translationally	 associated	 with	 membrane	 proteins	 without	 extra	 processing,	 which	 enables	
direct	prototyping	of	a	complete	biocircuit	with	TX-TL	produced	membrane	protein(s).			
	
We	intend	to	optimize	our	binding	assays	and	perform	competitive	binding	experiments	to	test	
the	 stringency	 of	 this	 assay.	 	 We	 envision	 that	 GPCR	 co-expressed	 with	 G	 protein	 can	 be	
expressed	by	TX-TL	to	test	the	biological	circuit	including	signal	transduction.		
	
Additionally,	 histidine	 kinases,	 which	 phosphorylate	 corresponding	 response	 regulators,	 can	
activate	downstream	transcription	and	translation.	We	have	started	tested	some	hybrid	histidine	
kinases	 and	 have	 seen	 promising	 results.	 Our	 goal	 is	 to	 prototype	 a	 logic	 biocircuit	 with	
membrane	enzyme	in	it,	expanding	TX-TL	platform	to	broader	topics.	
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Materials	and	Methods:	
	
Plasmids	and	linear	DNAs:	
DNA	 and	 oligonucleotides	 primers	 were	 ordered	 from	 Integrated	 DNA	 Technologies	 (IDT,	
Coralville,	Iowa).	Plasmids	in	this	study	were	designed	in	Geneious	8	(Biomatters,	Ltd.)	and	were	
made	using	standard	golden	gate	assembly	(GGA)	protocols.	BsaI-HF	(R3535S)	enzyme	used	in	
GGA	was	purchase	from	New	England	Biolabs	(NEB).	Linear	DNAs	were	made	by	PCRing	protein	
expression	related	sequences	out	of	GGA	constructs	using	Phusion	Hot	Start	Flex	2X	Master	Mix	
(M0536L)	from	NEB.	
	
TX-TL	reactions:	
TX-TL	reaction	mix	was	set	up	according	to	previous	 JOVE	paper[5].	Briefly,	TX-TL	extract	and	
buffer	were	mixed	together	with	calculated	linear	DNAs	or	plasmids	with	or	without	nanodiscs.	
Reaction	volumes	varied	from	10µL	(initial	screening)	to	1mL	(protein	purification	and	analysis).	
	
Gel	and	western	blot:	
Gels	used	in	this	work	were	Bolt	4–12%	Bis-Tris	Plus	Gels	from	ThermoFisher	Scientific.	Running	
buffer	was	Bolt	MES	SDS	Running	Buffer.	Gels	were	run	without	reducing	agents.	Protein	samples	
were	mixed	with	LDS	sample	buffer	before	loading	into	gels.	iBlot	2	Gel	Transfer	Device	and		
iBlot	 Nitrocellulose	 Regular	 Stacks	 were	 used	 for	 transfer	 proteins	 from	 gel	 to	 membrane.	
Membrane	was	then	transferred	to	iBind	device	and	incubated	with	Penta-His	HRP	Conjugate	in	
1:500	dilutions.	Blots	were	detected	using	SuperSignal	Chemiluminescent	HRP	Substrates	from	
ThermoFisher	Scientific.	
	
Protein	purification:	
TX-TL	reaction	mix	was	first	spun	@14,000g	for	10min	at	4°C.	Supernatant	was	then	transferred	
to	 buffer-equilibrated	 HisPur	 Ni-NTA	 Spin	 Purification	 column	 (ThermoFisher	 Scientific)	 and	
incubated	with	shaking	for	1h.	Then	spun	down	the	flow	through	@2000g	for	2min	and	washed	
with	nanodisc	buffer	(20	mM	Tris	pH	7.4,	0.1	M	NaCl)	added	with	20mM	imidazole	three	times.	
Elution	was	done	by	adding	elution	buffer	(20	mM	Tris	pH	7.4,	0.1	M	NaCl,	250mM	imidazole)	for	
3	times	2	column	volume.	Proteins	were	then	concentrated	using	Amicon	Ultra	Centrifugal	Filter	
Units	(Millipore)	with	Ultracel-30	membrane.	
	
Fluorescence-based	carazolol	binding	assay:	
Carazolol	 was	 purchased	 from	 Abcam	 (S)-Carazolol	 Fluorescent	 ligand	 (Red)	 ab118171.	 Each	
purified	 protein	 was	 first	 divided	 into	 two	 equal	 volume	 samples.	 One	 was	 added	 100nM	
carazolol	(dissolved	in	water)	and	the	other	one	was	added	the	same	volume	of	water.	They	were	
incubated	at	 4°C	 for	 1h	before	 transferred	 to	mini	 10k	MW	D-Tube	Dialyzers	 (Millipore)	 and	
dialyzed	 against	 100x	 volume	 of	 nanodisc	 buffer	 for	 overnight.	 Then	 dialyzed	 samples	 were	
concentrated	using	Amicon	Ultra	Centrifugal	Filter	Units	(Millipore)	with	Ultracel-30	membrane	
to	 starting	 volume.	 Samples	 were	 then	 put	 into	 BIOTEK	 Synergy	 H1	 Hybrid	 Multi-Mode	
Microplate	Reader	and	measured	for	GFP	fluorescence	(ex485nm/em525nm)	with	gain	61	or	gain	
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100	or	Red	fluorescence	(ex633nm/650nm)	with	optimal	gain.	GFP	fluorescence	was	converted	
to	nM	using	calibration	data	from	purified	GFP	protein.	
	
Surface	Plasmon	Resonance	(SPR)	based	norepinephrine	binding	assay:	
GE	Biacore	T-200	SPR	system	was	used	for	SPR	experiment.	Gold	plated	chip	was	first	immobilized	
with	norepinephrine	and	then	washed	away	extra	chemical.	There	are	four	channels	on	one	chip.	
Two	were	used	as	experimental	channels	and	the	remaining	two	were	used	as	negative	controls	
to	provide	background	response	from	buffer.	One	sample	was	incubated	with	1µM	carazolol	for	
1h	at	to	test	binding	specificity	and	the	other	sample	was	incubated	with	same	volume	of	water.	
Samples	 were	 then	 loaded	 and	 flowed	 through	 corresponding	 experimental	 channels	 and	
response	curves	were	recorded.	
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